A shared agenda for gender and COVID-19 research: priorities based on broadening engagement in scienceBMJ GLOBAL HEALTHIF6.12023-05-224OAAI
Gender equality by 2045: reimagining a healthier future for women and girlsBMJ-BRITISH MEDICAL JOURNALIF42.72021-06-286OAAI
Priority-setting to integrate sexual and reproductive health into universal health coverage: the case of MalaysiaSEXUAL AND REPRODUCTIVE HEALTH MATTERSIF2.62020-11-258OAAI
Employment based health financing does not support gender equity in universal health coverageBMJ-BRITISH MEDICAL JOURNALIF42.72020-10-2712OA
Investing in the health of girls and women: a best buy for sustainable developmentBMJ-BRITISH MEDICAL JOURNALIF42.72020-06-0215OAAI
Prioritising gender, equity, and human rights in a GRADE-based framework to inform future research on self care for sexual and reproductive health and rightsBMJ GLOBAL HEALTHIF6.12020-03-306OAAI
Financing intersectoral action for health: a systematic review of co-financing modelsGLOBALIZATION AND HEALTHIF4.52019-12-1836OAAI
Self care interventions for sexual and reproductive health and rights: costs, benefits, and financingBMJ-BRITISH MEDICAL JOURNALIF42.72019-04-0132OAAI
Building a tuberculosis-free world: The Lancet Commission on tuberculosisLANCETIF88.52019-03-01254OAAI
Investing in sexual and reproductive health and rights of women and girls to reach HIV and UHC goalsLANCET GLOBAL HEALTHIF182018-10-0116OAAI
Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral PerspectiveVALUE IN HEALTHIF62017-04-0136OAAI
Financing the HIV response in sub-Saharan Africa from domestic sources: Moving beyond a normative approachSOCIAL SCIENCE & MEDICINEIF52016-11-0138OAAI
Secondary schooling might be as good an HIV investment as male circumcisionLANCET GLOBAL HEALTHIF182015-10-015OAAI
Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countriesBULLETIN OF THE WORLD HEALTH ORGANIZATIONIF5.72014-04-0151OAAI
Financing structural interventions: going beyond HIV-only value for money assessmentsAIDSIF3.12014-01-2846OAAI
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsLANCET GLOBAL HEALTHIF182014-01-01173OAAI
Financing tuberculosis control: promising trends and remaining challengesLANCET GLOBAL HEALTHIF182013-08-014OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向